Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community - Roberto Pecoits-Filho, MD, PhD; Michelle M.Y. Wong, MD; Monica Moorthy, MSc; Debasish Banerjee, MD; Suman Behera, MD, FRCPC; Viviane Calice-Silva, MD, PhD; Mogamat-Yazied Chothia, PhD; Gates B. Colbert, MD; Martha Gulati, MD, MS; Charles A. Herzog, MD; Fadi Jouhra, MD; Edgar V. Lerma, MD; et al. (Kidney International Reports, 2025)